Letter brings together experts from across the country and includes UFLA participation

The historic investment from the Financier of Studies and Projects (Finep) will finance cutting-edge structures in two regions of the country. The approval, combined with recent authorizations from Anvisa, boosts the development of the scientific bases of the "CBD Brazil" project with the central goal of reducing the costs of medicinal products in Brazil, subsidizing the national production chain

Experts analyze the scenario and highlight that the measure meets Anvisa's expectations for the Brazilian market; Analysis reveals that the new legislation does not represent prohibition, but rather a restructuring of the sector focusing on taxation and pharmaceutical control

Event in São Paulo brings together regulators and experts to discuss regulation, cultivation, and the market landscape of the sector

Paulo Pereira launches Cannabis Global Co., a book that analyzes cannabis capitalism and the contradictions of cannabis legalization worldwide

Event gathered over 40 doctors and marked the beginning of the partnership between Sampa Cannabis and Santa Cannabis to expand access to cannabinoid medicine in Brazil

“Now is the time to devise strategies and discuss how to implement and improve the requirements that will come,” says Beatriz Marti Emygdio, researcher at Embrapa and president of the Permanent Committee on Cannabis (CPCAN)

Debates on medicinal cannabis continue deeply at Cannabis Connection 2025 in November and at the Brazilian Medicinal Cannabis Congress in May 2026, both in São Paulo.

Studies show efficacy of cannabinoids in controlling inflammation, acne, and itching, while Anvisa evaluates expanding regulations for topical products

From folk medicine to modern studies, the plant reveals its healing strength guided by the hands and knowledge of women

Document developed by a group with 31 Brazilian academic and research institutions points out regulatory barriers and suggests an agile framework to strengthen the scientific and technological sector

Study by USP and Fiocruz shows that cannabidiol may reverse symptoms associated with autism in an animal model, paving the way for new treatments of ASD

Decision allows the entity, which serves 9,000 patients, to operate again after a police action destroyed a cannabis plantation

Driven by the Epsilon variant, cannabis sales at pharmacies reach a historic mark with high consumer preference for higher THC content

Researchers propose THC units to measure cannabis consumption and identify levels associated with a higher risk of cannabis use disorder

Partnership will allow affiliated unions to offer medical care and therapies with cannabis to members and their families

Researchers point to CBD as promising in the treatment of endometriosis, with the potential to reduce pain, inflammation, and associated symptoms, although robust clinical trials are still lacking

Scientific survey indicates that cannabidiol may interfere with mechanisms related to the progression and spread of tumors in different types of cancer

A study followed 204 adults with chronic pain and revealed that adherence to the medicinal cannabis program is associated with a significant reduction in opioid use over 18 months

Study shows that the combination of cannabis and propolis extracts can enhance antibacterial and anti-inflammatory effects, pointing to new possibilities for natural therapies